Company Filing History:
2 out of 38 
1 out of 1 
1 out of 1,187 
Years Active: 1991-2005
Title: Kaare M Gautvik: Innovator in Biotechnology
Introduction
Kaare M Gautvik is a prominent inventor based in Oslo, Norway. He has made significant contributions to the field of biotechnology, particularly in the production of human parathyroid hormone and hypothalamus-specific polypeptides. With a total of 5 patents, Gautvik's work has advanced our understanding of hormone production and its applications.
Latest Patents
One of Gautvik's latest patents focuses on the production of human parathyroid hormone from microorganisms. This invention provides recombinant plasmids containing DNA sequences coding for human preproparathyroid hormone. The invention further includes microorganisms transformed by these plasmids, as well as a plasmid for insertion into yeast. The transformed yeast secretes parathyroid hormone, which has significant implications for medical treatments. Additionally, the patent outlines methods for purifying the secreted PTH hormone and its derivatives. Another notable patent involves hypothalamus-specific polypeptides, which includes hypocretin polynucleotides and hypocretin polypeptides. These biologically active polypeptides are localized in the hypothalamus and play a crucial role in appetite and feeding behavior.
Career Highlights
Throughout his career, Gautvik has worked with various companies, including NPS Allelix Corporation and Selmer-Sande, A.S. His innovative research has positioned him as a key figure in the biotechnology sector, contributing to advancements that have the potential to improve health outcomes.
Collaborations
Gautvik has collaborated with notable individuals in his field, including Peter Alestrom and Odd Stokke Gabrielsen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Kaare M Gautvik's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field, paving the way for future advancements in hormone production and therapeutic applications.